How Your Gut Bacteria and Your Body's Cannabis-Like System Talk to Each Other

The gut microbiota and endocannabinoidome interact bidirectionally: gut bacteria influence endocannabinoid levels and receptor expression, while endocannabinoid signaling shapes gut microbial composition and intestinal barrier function. Diet and exercise modulate both systems. These interactions are implicated in IBD, depression, anxiety, Alzheimer's, and metabolic disorders.

Narrative review examining molecular mechanisms and signaling pathways linking the gut microbiota and endocannabinoidome. Analyzes the role of dietary patterns and physical activity in regulating these interactions across multiple disease conditions.

The gut-endocannabinoid axis represents a new frontier for understanding how cannabis affects health beyond direct receptor activation. Many of cannabis's effects on mood, inflammation, and metabolism may be mediated through gut microbiome changes.

This review positions the gut-endocannabinoid axis as a unifying mechanism for many of cannabis's diverse health effects. If cannabis changes gut bacteria, and gut bacteria change endocannabinoid signaling, the therapeutic implications extend far beyond what direct receptor studies have revealed.

Narrative review — not systematic. Many findings from animal models with limited human data. Mechanistic understanding is still emerging. Cannot determine if gut microbiome changes are causes or consequences of disease states.